Peter Haahr

Board member since 2021

Nationality: Danish

Born: 1968

Non-independent

Board committees, LEO Pharma

Member of the Audit Committee, the Remuneration and Nomination Committee and the Innovation Committee.

Positions and management duties

CEO of the LEO Foundation and LEO Holding. Chair of LH Capital and House of Denmark. Board member of the World Diabetes Foundation.

Career

Former CFO of Novo Holdings and, prior to this, held various leadership roles at Novo Nordisk, including Head of Investor Relations. Earlier career as an equity analyst.

Special competencies

Extensive international experience in strategy, business development, financial planning, investor relations and leadership at Novo Nordisk. Led the risk and capital allocation committee, developed the investment strategy and implemented efficiency programs at Novo Holdings. Managed foundation initiatives and business development at the LEO Foundation and LEO Holding. Skilled in risk management, governance, investor relations and global financial oversight.